(one myocardial infarction; one atrial fibrillation). At four hours postadmission, 14 more patients tested positive (13 myocardial infarction and one angina). At 12 hours postadmission, a further seven patients tested positive (five myocardial infarction and two angina).
Of the 19 patients diagnosed as myocardial infarction, a positive troponin T was only present in one patient on admission, and in 13 patients at four hours postadmission. All patients with myocardial infarction had a positive troponin test at 12 hours postadmission.
The TropT slides may be useful at 12 hours to exclude myocardial injury but do not offer improvements in the diagnosis of myocardial infarction in the first hours after presentation at an accident and emergency department.
Through the trial we made some observations which should be carefully considered when using TropT slides, especially in areas outside the clinical laboratory. (1) A good light source is required to read the slide, as the positive line can often be faint and the stick needs to be carefully assessed. (2) It is essential to ensure that 20 minutes elapse before reading the slide, as samples with levels of troponin T close to the sensitivity of the assay only develop after this time. The negative control line often develops within 10 minutes and this could lead to the stick result being misinterpreted in the absence of careful timing. These factors are likely to lead to problems in busy clinical areas, where necessary care with the timing and interpretation of the result may not always occur. (3) Sample handling is also important, and well mixed blood free from haemolysis is required. Since whole blood is used, haemolysis is only apparent on causing a red/brown colouration of the reading area.
We believe that when designing slide tests for use outside the laboratory, manufacturers should ensure that the strength of signal line for a positive result is clear, especially at low levels of the measured analyte. The strength of the negative control line should be equivalent to the signal line obtained by a weakly positive test and should appear after the assay reaction time has been reached to ensure that slides are not read inappropriately early.
In summary, the use of slide tests appears to be very simple but valid results are only obtained with careful and consistent use. The crucial role of the laboratory in the safe use of glucose meters outside of the laboratory is widely accepted.4 When clinicians are evaluating slide based tests for use at the patient's bedside they should seek the advise of their laboratory in the choice, evaluation, and training of staff in the use of these systems. Only with such collaboration will such assay systems lead to improvements in patient care. A 68 year old man was admitted with a tonic generalised convulsion. He had a 40 year history of heavy alcohol intake and recurrent minor head traumas, although computerised tomography of the head showed nothing abnormal. Tonic generalised convulsions, each lasting for about one minute, occurred repeatedly. The interval between attacks was about 15 minutes, during which he was unresponsive to verbal stimuli. Diazepam 10 mg was given intravenously with no effect. Phenytoin 750 mg intravenously was then given and the level of consciousness improved within two hours. However, a right tonic hemiconvulsion persisted, although the interval was prolonged to three to four hours on the day after admission. Despite of the additional administration of 1000 mg of phenytoin intravenously over the following 24 hours, the right tonic hemiconvulsion recurred.
An intravenous bolus of 100 mg lignocaine was therefore given during the attack, and the convulsion completely disappeared within about 30 seconds. The patient was then given a continuous intravenous infusion of lignocaine, 1 mg/min, and oral phenytoin, 300 mg/day. Status epilepticus did not recur. On day 10, the lignocaine was discontinued and convulsions did not recur thereafter. The electroencephalogram on day 12 revealed no epileptic findings.
Currently, lignocaine is considered as the third line agent in the treatment of status epilepticus when first line agents, such as diazepam and phenytoin, and second line agents, such as barbiturates, fail to control seizures.1 However, the best treatment for focal status epilepticus has not yet been established, although barbiturates, carbamazepine, and phenytoin are recommended. A&E, 21% to attend their GP, and 31% given home care advice. We found similar support from the nursing staff using the system. We also found that 53% of callers (n = 81) were aware that the nurse was using a computer, and the majority (75%) believed it to be a good idea to use computers to provide clinical on September 20, 2019 by guest. Protected by copyright.
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